Preliminary Outcomes for Treatment of High Intermediate- and High-risk Prostate Cancer Patients using Pelvic Intensity Modulated Radiotherapy with Hypofractionated Simultaneous Integrated Boost to Prostate

被引:2
|
作者
Reddy, K. [1 ]
Nelson, B. C. [1 ]
McCammon, R. [2 ]
Rusthoven, K. E. [1 ]
Newman, F. [1 ]
Kavanagh, B. [1 ]
Raben, D. [1 ]
机构
[1] Univ Colorado, Aurora, CO USA
[2] SE Radiat Oncol, Charlotte, NC USA
关键词
D O I
10.1016/j.ijrobp.2010.07.887
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S376 / S376
页数:1
相关论文
共 50 条
  • [31] Hypofractionated Intensity Modulated Radiation Therapy to Prostate and Pelvic Nodes Plus Androgen Suppression in High-Risk Prostate Cancer
    Faria, S. L.
    Cury, F.
    Duclos, M.
    Souhami, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S146 - S146
  • [32] IMRT simultaneous integrated boost for high-risk prostate cancer
    Li, X
    Wang, JZ
    Jursinic, P
    Lawton, CA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S632 - S633
  • [33] Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer
    Folkert, Michael R.
    Shih, Karin K.
    Abu-Rustum, Nadeem R.
    Jewell, Elizabeth
    Kollmeier, Marisa A.
    Makker, Vicky
    Barakat, Richard R.
    Alektiar, Kaled M.
    GYNECOLOGIC ONCOLOGY, 2013, 128 (02) : 288 - 293
  • [34] Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: Acute toxicity result
    Lim, Tee S.
    Cheung, Patrick C. F.
    Loblaw, D. Andrew
    Morton, Gerard
    Sixel, Katharina E.
    Pang, Geordi
    Basran, Parminder
    Zhang, Liying
    Tirona, Romeo
    Szumacher, Ewa
    Danjoux, Cyril
    Choo, Richard
    Thomas, Gillian
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : 85 - 92
  • [35] Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer
    Houben, Jeroen
    McColl, Gill
    Kaanders, Johannes Ham
    Smeenk, Robert J.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 29 : 40 - 46
  • [36] Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer
    C. Franzese
    A. Fogliata
    G. R. D’Agostino
    L. Di Brina
    T. Comito
    P. Navarria
    L. Cozzi
    M. Scorsetti
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 1301 - 1309
  • [37] Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer
    Franzese, C.
    Fogliata, A.
    D'Agostino, G. R.
    Di Brina, L.
    Comito, T.
    Navarria, P.
    Cozzi, L.
    Scorsetti, M.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (07) : 1301 - 1309
  • [38] Comparing the Cost Effectiveness of Hypofractionated EBRT with High Dose Rate Brachytherapy Boost and Intensity Modulated Radiation Therapy for the Treatment of Intermediate/High-Risk Prostate Cancer
    Lanni, T. B.
    Ghilezan, M. I.
    Gustafson, G. S.
    Marvin, K. S.
    Ye, H.
    Martinez, A. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S359 - S359
  • [39] Outcomes of intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer: a single-institutional study
    Sasamura, Kazuma
    Soyano, Takashi
    Kozuka, Takuyo
    Yuasa, Takeshi
    Yamamoto, Shinya
    Yonese, Junji
    Oguchi, Masahiko
    Yoshimura, Ryoichi
    Yoshioka, Yasuo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (02) : 170 - 178
  • [40] WHOLE-PELVIC NODAL IRRADIATION WITH HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST FOR HIGH-RISK PROSTATE CANCER: OUTCOME AND LATE TOXICITY
    Magli, Alessandro
    Moretti, Eugenia
    Tullio, Annarita
    Ceschia, Tino
    Chiaulon, Germana
    Parisi, Giuseppe
    Signor, Marco Andrea
    Crespi, Margherita
    Foti, Claudio
    De Giorgi, Gioacchino
    Sacco, Cosimo Stanislao
    ANTICANCER RESEARCH, 2017, 37 (04) : 2070 - 2071